MU Stage1 Final Rule - Drug-Drug Drug-Allergy Checks
SECTION # Section 170.302(a)—Drug-Drug, Drug-Allergy, Drug-Formulary Checks
MU OBJECTIVE Implement drug-drug and drug-allergy interaction checks
MU STAGE 1 MEASURE The EP/eligible hospital/CAH has enabled this functionality for the entire EHR reporting period
CERTIFICATION CRITERION Final Rule Text: §170.302(a). (1) Notifications. Automatically and electronically generate and indicate in real-time, notifications at the point of care for drug- drug and drug-allergy contraindications based on medication list, medication allergy list, and computerized provider order entry (CPOE). (2) Adjustments. Provide certain users with the ability to adjust notifications provided for drug-drug and drug-allergy interaction checks.
STANDARDS N/A
TEST CRITERIA # §170.302 (a) http://healthcare.nist.gov/docs/170.302.a_DrugDrugDrugAllergy_v1.0.pdf
USERS | CORE / MENU | SOLUTION DEVELOPERS | STATUS |
---|---|---|---|
All | CORE | Oroville | In development |
SOLUTION DESIGN / TECHNOLOGY (Add details here)
SOLUTION COMPONENTS (Add details here - Ex. KIDS patch, Delphi code, User guide, Web resources, Manual test script, etc)
DEPENDENCIES (Add details here)
COMMENTS / NOTES (Add details here)
PREVIOUS NOTES Note: VistA currently doesn't maintain formularies. This will need to be done with an interface to a 3rd party application, such as the NewCrop ePrescibing service. Drug interactions are handled in VistA but because of the additional requirements, the cur
DEVELOPMENT STATUS (Add details here)
ACTION ITEMS / NEXT STEPS (Add details here)
OPEN ISSUES / QUESTIONS (Add details here)